Have a personal or library account? Click to login
Early and Late Outcome After Suprasonic Excision of Infected Mesh Implants After Hernioplasty Cover

Early and Late Outcome After Suprasonic Excision of Infected Mesh Implants After Hernioplasty

Open Access
|Dec 2019

Figures & Tables

The outcomes according to the procedure

CharacteristicGroup I, n = 78Group II, n = 71p
Operation time, min141.5 (101–153)84.3 (54.2–93.7)0.002*
Bleeding, n (%)7 (8.9)1 (1.4)0.035
Residual fragments of meshes, n (%)13 (16.6)1 (1.4)0.003
Eventration, n (%)3 (3.8)0 (0.0)0.003
LHS, days14 (7–23)7 (3–18)0.001*
SOI, days1 (0–6)1 (5–14)0.016*
SSI, n (%)9 (11.5)2 (2.8)0.044

The characteristics before surgery according to the procedure

CharacteristicGroup I, n = 78Group II, n = 71p
Age, years30.7 (8.8–84.1)39.4 (6.1–87.7)0.037*
Gender, M/F23/5520/510.653
Time between operation, month9.2 (6.5–11.3)8.4 (7.1–10.2)0.7*
WBC (103/μL)12.3 (4.3–26.5)13.0 (4.4–36.4)0.160*
Alb (g/dL)4.4 (2.8–5.3)4.4 (2.5–5.3)0.154*
Neutro. (%)80.9 (43.0–95.5)83.6 (27.6–95.5)0.674*
Lymph (%)13.0 (3–46)10.9 (3–57.8)0.666*

Recurrence of ventral hernias

ReherniationGroup 1 (n=78)Group II (n=71)p
Patients, n (%)11 (14.1)6 (8.5)0.002

Multivariate analysis clinical and operative factors according to the procedure

IndicatorsGroup I (n=78)Group II (n=71)Odd ratio95% CIp
Bleeding, n (%)7 (8.9)1 (1.4)2.291.04–4.970.035
LHS, days14 (7–23)7 (3–18)2.031.12–3.710.001
Reherniation, n (%)11 (14.1)6 (8.5)2.41.09–3.920.002
DOI: https://doi.org/10.2478/sjecr-2018-0054 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 313 - 317
Submitted on: Jul 10, 2018
Accepted on: Aug 3, 2018
Published on: Dec 31, 2019
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Vladimir S. Panteleev, Vitaliy A. Zavarukhin, Mariya P. Pogorelova, Aleksandr V. Samorodov, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.